DiaSorin - The Diagnostic Specialist
Borsa Milano volatile, cede a realizzi dopo rally recente, giu' banche, Diasorin | Reuters
Annual Financial Report
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
LIAISON® XL | DiaSorin
DiaSorin Inc. | LinkedIn
Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
DiaSorin Inc. | DiaSorin
DiaSorin Inc. | LinkedIn
Meet our People | DiaSorin
Results | DiaSorin
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
DiaSorin - The Diagnostic Specialist
DiaSorin
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin | Saluggia
DiaSorin concludes acquisition of Luminex for $1.8bn
Borsa: Milano frena ancora (-1,1%), pesano Diasorin e Stellantis - Notizie - Ansa.it
LIAISON® XL | DiaSorin
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
DiaSorin to Buy Covid-19 Test-Maker Luminex for $1.8 Billion - Bloomberg
Annual Financial Report
COVID-19 | Updates | DiaSorin
DiaSorin buys out rival diagnostics firm Luminex for $1.8bn
DiaSorin Spa Italy - DiaSorin Molecular
Medical Countermeasures | USA Public Health Security
Untitled
DiaSorin | Saluggia
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
Simplexa® SARS-CoV-2 Variants Direct (RUO) - DiaSorin Molecular
Results | DiaSorin
DiaSorin - The Diagnostic Specialist
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube
DiaSorin | Saluggia
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
DiaSorin S.p.A. | DiaSorin
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
Press Release
DiaSorin | Saluggia
Homepage - DiaSorin Molecular
Milan: DiaSorin on the rise - Borsa Italiana
DiaSorin | Saluggia
DiaSorin Italia S.p.A. | DiaSorin
Milan: downside move for DiaSorin - Borsa Italiana
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
